Bharat Biotech's nasal vaccine gets nod of regulator for phase 2/3 trial
Published By : Sourabha Parida | August 13, 2021 6:56 PM
Share
New Delhi, August 13: Bharat Biotech's intranasal vaccine is the first nasal vaccine that has received the regulatory approval for phase 2/3 trials. This is the first of its kind COVID-19 jab to undergo human clinical trials in India. BBV154 is an intranasal replication-deficient chimpanzee adenovirus SARS-CoV-2 vectored vaccine. BBIL has in-licensed technology from Washington University in St Louis, USA. Phase 1 clinical trial has been completed in age groups ranging ≥18 to ≤60 years. The company reports that the doses of the vaccine administered to healthy volunteers in the phase I clinical trial, has been well tolerated. No serious adverse events reported. Previously, the vaccine was found to be safe, immunogenic and well tolerated in the pre-clinical toxicity studies. The vaccine was able to elicit high level of neutralizing antibodies in animal studies. The regulatory approval has been received for conducting “A Phase 2 randomized, multi-centric, Clinical Trial of Heterologus Prime-Boost Combination of SARS-CoV-2 Vaccines to evaluate the immunogenicity and safety of BBV152 (COVAXIN®) with BBV154 (Adenoviral Intranasal COVID-19 vaccine) in healthy volunteers.” Dr Renu Swarup, Secretary, DBT and Chairperson, BIRAC speaking on the subject said that Bharat Biotech’s BBV154 Covid Vaccine is the first intranasal vaccine being developed in the country entering into late-stage clinical trials.
Prameya English Is Now On WhatsApp Join And Get Latest News Updates Delivered To You Via WhatsApp
You Might Also Like
More From Related News
PM Modi initiates projects worth over Rs 5,400 crore for WB
Chhattisgarh liquor scam: ED arrests Bhupesh Baghel’s son Chaitanya
PM Modi launches development projects worth over Rs 7,000 crore in Bihar
Indian Navy to commission first indigenous Diving Support Vessel ‘Nistar’ today
Amarnath Yatra 2025 resumes after one-day suspension, 7,908 devotees leave for valley
Bengaluru vendors ditch UPI, opt for cash to escape GST scrutiny
Bomb threat on Mumbai-Ahmedabad flight: Caller threats to blow up CSMI Airport
Actress Ranya Rao jailed for a year, no bail granted in Gold smuggling case
BTech student dies by suicide in UP’s Barabanki, alleges extortion by girlfriend in video
ED attaches properties worth ₹37.64 crore linked to Robert Vadra, files chargesheet in Gurugram land case
Goa-bound IndiGo flight makes emergency landing after developing engine failure mid-air
Earthquake hits Haryana’s Rohtak
From the ISS to a Family Embrace: The Emotional Homecoming of Shubhanshu Shukla
"Blood Cannot Be Bought": Victim's Family Rejects Pardon for Nimisha Priya, Demanding Retributive Justice
Ashwini Vaishnaw announces free AI training for 5.5 lakh CSC entrepreneurs
Jindal Foundation honoured with CSR TIMES Gold Award for promoting Sports
Patna-bound IndiGo flight performs go-around during landing at Jay Prakash Narayan International Airport
Union Cabinet approves PM Dhan-Dhaanya Krishi Yojana; 100 districts to be covered
"They Fired in Celebration": Key Witness Details Horrific Aftermath of Pahalgam Tourist Killings
Bhubaneswar to host 2-day national conference on ‘Good Governance Practices’ from tomorrow